tigatuzumab   Click here for help

GtoPdb Ligand ID: 9334

Synonyms: CS-1008 | humanized LM1 TRA-8
Compound class: Antibody
Comment: Tigatuzumab (CS-1008) is an investigational, humanized agonistic monoclonal antibody directed against human death receptor 5 (TNFRSF10B; a TNF family catalytic receptor for TRAIL), which is expressed on the surface of many types of cancer cells. DR5 contains an intracellular death domain and interacts with FADD (Fas-associated protein with death domain) to mediate apoptisis.
Peptide sequences and structural information for this antibody are available from its IMGT/mAb-DB record. Peptide sequences matching the heavy and light chain variable regions of tigatuzumab are claimed in patent WO2001083560 [1], but this does not provide an affinity value for the antibody vs. DR5. The antibodies described in the patent were tetsed for their ability to induce apoptosis in cells expressing DR5.
Click here for help
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
8979 tigatuzumab
Synonyms Click here for help
CS-1008 | humanized LM1 TRA-8
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 234
Other databases
GtoPdb PubChem SID 318164853
Search PubMed clinical trials tigatuzumab
Search PubMed titles tigatuzumab
Search PubMed titles/abstracts tigatuzumab